LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 240

Search options

  1. Article ; Online: Sterol biosynthesis regulates TLR signaling and the innate immune response in a Smith-Lemli-Opitz syndrome model.

    Gabor, Kristin / Mesev, Emily V / Madenspacher, Jennifer / Meacham, Julie / Rai, Prashant / Moon, Sookjin / Wassif, Christopher A / Shaikh, Saame Raza / Tucker, C J / Karmaus, Peer / Bianconi, Simona / Porter, Forbes D / Fessler, Michael B

    The Journal of clinical investigation

    2024  Volume 134, Issue 6

    MeSH term(s) Humans ; Smith-Lemli-Opitz Syndrome/genetics ; Cholesterol ; Immunity, Innate
    Chemical Substances Cholesterol (97C5T2UQ7J)
    Language English
    Publishing date 2024-01-18
    Publishing country United States
    Document type Journal Article
    ZDB-ID 3067-3
    ISSN 1558-8238 ; 0021-9738
    ISSN (online) 1558-8238
    ISSN 0021-9738
    DOI 10.1172/JCI167633
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Cerebrospinal Fluid Protein Biomarker Discovery in CLN3.

    Dang Do, An N / Sleat, David E / Campbell, Kiersten / Johnson, Nicholas L / Zheng, Haiyan / Wassif, Christopher A / Dale, Ryan K / Porter, Forbes D

    Journal of proteome research

    2023  Volume 22, Issue 7, Page(s) 2493–2508

    Abstract: Syndromic CLN3-Batten is a fatal, pediatric, neurodegenerative disease caused by variants ... ...

    Abstract Syndromic CLN3-Batten is a fatal, pediatric, neurodegenerative disease caused by variants in
    MeSH term(s) Humans ; Child ; Molecular Chaperones/metabolism ; Cerebrospinal Fluid Proteins ; Membrane Glycoproteins/metabolism ; Neurodegenerative Diseases ; Proteomics ; Neuronal Ceroid-Lipofuscinoses/genetics ; Neuronal Ceroid-Lipofuscinoses/metabolism
    Chemical Substances Molecular Chaperones ; Cerebrospinal Fluid Proteins ; Membrane Glycoproteins
    Language English
    Publishing date 2023-06-20
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Intramural
    ZDB-ID 2078618-9
    ISSN 1535-3907 ; 1535-3893
    ISSN (online) 1535-3907
    ISSN 1535-3893
    DOI 10.1021/acs.jproteome.3c00199
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Sterol O-Acyltransferase 1 (

    Farhat, Nicole Y / Alexander, Derek / McKee, Kyli / Iben, James / Rodriguez-Gil, Jorge L / Wassif, Christopher A / Cawley, Niamh X / Balch, William E / Porter, Forbes D

    International journal of molecular sciences

    2024  Volume 25, Issue 8

    Abstract: Niemann-Pick disease type C1 (NPC1) is a lysosomal disorder due to impaired intracellular cholesterol transport out of the endolysosomal compartment.. Marked heterogeneity has been observed in individuals with the ... ...

    Abstract Niemann-Pick disease type C1 (NPC1) is a lysosomal disorder due to impaired intracellular cholesterol transport out of the endolysosomal compartment.. Marked heterogeneity has been observed in individuals with the same
    MeSH term(s) Niemann-Pick Disease, Type C/genetics ; Niemann-Pick Disease, Type C/metabolism ; Humans ; Male ; Female ; Sterol O-Acyltransferase/genetics ; Sterol O-Acyltransferase/metabolism ; Niemann-Pick C1 Protein ; Child ; Polymorphism, Single Nucleotide ; Animals ; Mice ; Phenotype ; Adolescent ; Child, Preschool ; Genes, Modifier ; Adult ; Alleles ; Severity of Illness Index ; Genotype ; Intracellular Signaling Peptides and Proteins/genetics ; Intracellular Signaling Peptides and Proteins/metabolism ; Young Adult
    Chemical Substances Sterol O-Acyltransferase (EC 2.3.1.26) ; sterol O-acyltransferase 1 (EC 2.3.1.26) ; Niemann-Pick C1 Protein ; NPC1 protein, human ; Intracellular Signaling Peptides and Proteins
    Language English
    Publishing date 2024-04-11
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms25084217
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Brain proton MR spectroscopy measurements in CLN3 disease.

    Dang Do, An N / Baker, Eva H / Farmer, Cristan A / Soldatos, Ariane G / Thurm, Audrey E / Porter, Forbes D

    Molecular genetics and metabolism

    2023  Volume 139, Issue 1, Page(s) 107584

    Abstract: Background: CLN3 is an autosomal recessive lysosomal disorder with intracellular accumulation of ceroid-lipofuscins. CLN3 classically has onset around 4-6 years of age involving vision loss, followed by developmental regression and seizures. Symptoms ... ...

    Abstract Background: CLN3 is an autosomal recessive lysosomal disorder with intracellular accumulation of ceroid-lipofuscins. CLN3 classically has onset around 4-6 years of age involving vision loss, followed by developmental regression and seizures. Symptoms are progressive and result in premature death. Because treatments are under development, here we explore magnetic resonance spectroscopy (MRS) measurements of metabolite levels in the brain as a potential objective outcome measures.
    Methods: Individuals with genetically confirmed CLN3 were enrolled from October 2017-November 2021 in a prospective natural history study (NCT033007304). Baseline concentrations of brain metabolites measured by MRS were compared to concurrently collected dimensional assessment measures: Vineland-3 Adaptive Behavior Composite (ABC) score, verbal intelligence quotient (VIQ), and the Physical, Capability with actual vision, and Clinical global impression of change sub-domains of the Unified Batten Disease Rating Scale (UBDRS).
    Results: 27 participants with typical CLN3 presentation (15F:12M; ages 6.0-20.7 years) completed MRS, ABC, and UBDRS; 20 (12F:8M; ages 6.5-20.7 years) also completed the VIQ assessment. N-acetyl aspartate [B(95% CI) = -0.61(-0.78;-0.45)] and glutamine/glutamate/GABA [B(95% CI) = -0.82(-1.04;-0.6)] in the parietal gray matter (PGM) decreased across the ages. The strongest correlations between MRS metabolite measurements and the clinical severity assessments were found with N-acetyl aspartate [VIQ (ρ = 0.58), Vineland-3 ABC (ρ = 0.59), UBDRS |ρ| range = (0.57;0.7)] and glutamine/glutamate/GABA [VIQ (ρ = 0.57), Vineland-3 ABC (ρ = 0.60), UBDRS |ρ| range = (0.59;0.77)] measured in the midline PGM. These correlations were accounted for when age was considered.
    Conclusions: Based on their correlations to established assessments, NAA and glutamine/glutamate/GABA measured in the midline parietal gray matter may be useful indicators of CLN3 disease state. In a clinical trial, divergence of the MRS measurements and clinical severity markers from age may be useful as surrogate measures for treatment responses.
    MeSH term(s) Humans ; Child ; Adolescent ; Young Adult ; Adult ; Protons ; Membrane Glycoproteins/metabolism ; Glutamine/metabolism ; Neuronal Ceroid-Lipofuscinoses/diagnosis ; Neuronal Ceroid-Lipofuscinoses/genetics ; Prospective Studies ; Brain/metabolism ; Magnetic Resonance Spectroscopy ; Glutamic Acid/metabolism ; gamma-Aminobutyric Acid/metabolism ; Molecular Chaperones/metabolism
    Chemical Substances Protons ; Membrane Glycoproteins ; Glutamine (0RH81L854J) ; Glutamic Acid (3KX376GY7L) ; gamma-Aminobutyric Acid (56-12-2) ; CLN3 protein, human ; Molecular Chaperones
    Language English
    Publishing date 2023-04-15
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, N.I.H., Intramural
    ZDB-ID 1418518-0
    ISSN 1096-7206 ; 1096-7192
    ISSN (online) 1096-7206
    ISSN 1096-7192
    DOI 10.1016/j.ymgme.2023.107584
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Defective iron homeostasis and hematological abnormalities in Niemann-Pick disease type C1.

    Chen, Oscar C W / Siebel, Stephan / Colaco, Alexandria / Nicoli, Elena-Raluca / Platt, Nick / Shepherd, Dawn / Newman, Stephanie / Armitage, Andrew E / Farhat, Nicole Y / Seligmann, George / Smith, Claire / Smith, David A / Abdul-Sada, Alaa / Jeyakumar, Mylvaganam / Drakesmith, Hal / Porter, Forbes D / Platt, Frances M

    Wellcome open research

    2023  Volume 7, Page(s) 267

    Abstract: ... ...

    Abstract Background
    Language English
    Publishing date 2023-04-03
    Publishing country England
    Document type Journal Article
    ISSN 2398-502X
    ISSN 2398-502X
    DOI 10.12688/wellcomeopenres.17261.2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Corrigendum to "Elevated amyloid beta peptides and total tau in cerebrospinal fluid in individuals with Creatine transporter deficiency".

    Rahhal, Samar / Farmer, Cristan / Thurm, Audrey / Wassif, Christopher A / Cawley, Niamh X / Perreault, John / Dang Do, An / Bianconi, Simona / Hannah-Shmouni, Fady / Guthrie, Whitney / Cubit, Laura S / Miller, Judith S / Sutton, V Reid / Koeberl, Dwight / Porter, Forbes D

    Molecular genetics and metabolism reports

    2023  Volume 37, Page(s) 101013

    Abstract: This corrects the article DOI: 10.1016/j.ymgmr.2023.101001.]. ...

    Abstract [This corrects the article DOI: 10.1016/j.ymgmr.2023.101001.].
    Language English
    Publishing date 2023-10-09
    Publishing country United States
    Document type Published Erratum
    ZDB-ID 2821908-9
    ISSN 2214-4269
    ISSN 2214-4269
    DOI 10.1016/j.ymgmr.2023.101013
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Phenotype assessment for neurodegenerative murine models with ataxia and application to Niemann-Pick disease, type C1.

    Yerger, Julia / Cougnoux, Antony C / Abbott, Craig B / Luke, Rachel / Clark, Tannia S / Cawley, Niamh X / Porter, Forbes D / Davidson, Cristin D

    Biology open

    2022  Volume 11, Issue 4

    Abstract: Identifying meaningful predictors of therapeutic efficacy from preclinical studies is challenging. However, clinical manifestations occurring in both patients and mammalian models offer significant translational value. Many neurological disorders, ... ...

    Abstract Identifying meaningful predictors of therapeutic efficacy from preclinical studies is challenging. However, clinical manifestations occurring in both patients and mammalian models offer significant translational value. Many neurological disorders, including inherited, metabolic Niemann-Pick disease, type C (NPC), exhibit ataxia. Both individuals with NPC and murine models manifest ataxia, and investigational therapies impacting this phenotype in mice have been reported to slow disease progression in patients (e.g. miglustat, intrathecal 2-hydroxypropyl-beta-cyclodextrin, and acetyl-L-leucine). Reproducible phenotypic scoring of animal models can facilitate comparisons between genotypes, sexes, disease course, and therapies. Previously, other groups have developed a composite phenotypic scoring system (CPSS), which was subsequently used to distinguish strain-dependent phenotypes and, with modifications, to evaluate potential therapies. However, high inter-rater reliability is paramount to widespread use. We have created a comprehensive, easy-to-follow phenotypic assessment based on the CPSS and have verified its reproducibility using murine models of NPC disease. Application of this scoring system is not limited to NPC disease and may be applicable to other models of neurodegeneration exhibiting motor incoordination, thereby increasing its utility in translational studies.
    MeSH term(s) Animals ; Ataxia/diagnosis ; Ataxia/etiology ; Disease Models, Animal ; Humans ; Mammals ; Mice ; Niemann-Pick Disease, Type C/diagnosis ; Niemann-Pick Disease, Type C/drug therapy ; Niemann-Pick Disease, Type C/genetics ; Phenotype ; Reproducibility of Results
    Language English
    Publishing date 2022-05-03
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Intramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2632264-X
    ISSN 2046-6390 ; 2046-6390
    ISSN (online) 2046-6390
    ISSN 2046-6390
    DOI 10.1242/bio.059052
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Statins for Smith-Lemli-Opitz syndrome.

    Ballout, Rami A / Bianconi, Simona / Livinski, Alicia / Fu, Yi-Ping / Remaley, Alan T / Porter, Forbes D

    The Cochrane database of systematic reviews

    2020  Volume 2020, Issue 1

    Abstract: This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: 1. To evaluate the efficacy of statin therapy in reducing the frequency or severity of the neurobehavioral abnormalities seen in people with SLOS (e.g. aggression, ... ...

    Abstract This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: 1. To evaluate the efficacy of statin therapy in reducing the frequency or severity of the neurobehavioral abnormalities seen in people with SLOS (e.g. aggression, anxiety, irritability, self-mutilation, autistic behaviors, sleep disturbances, etc.) (Wassif 2017). 2. To evaluate the potential effects of statin therapy on survival.
    Language English
    Publishing date 2020-03-16
    Publishing country England
    Document type Journal Article
    ISSN 1469-493X
    ISSN 1469-493X
    DOI 10.1002/14651858.cd013521
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Anesthesia outcomes in lysosomal disorders: CLN3 and GM1 gangliosidosis.

    Luckett, Amelia / Yousef, Muhammad / Tifft, Cynthia / Jenkins, Kisha / Smith, Andrew / Munoz, Andrea / Quimby, Rachel / Porter, Forbes D / Dang Do, An Ngoc

    American journal of medical genetics. Part A

    2022  Volume 191, Issue 3, Page(s) 711–717

    Abstract: Natural history studies of pediatric rare neurometabolic diseases are important to understand disease pathophysiology and to inform clinical trial outcome measures. Some data collections require sedation given participants' age and neurocognitive ... ...

    Abstract Natural history studies of pediatric rare neurometabolic diseases are important to understand disease pathophysiology and to inform clinical trial outcome measures. Some data collections require sedation given participants' age and neurocognitive impairment. To evaluate the safety of sedation for research procedures, we reviewed medical records between April 2017 and October 2019 from a natural history study for CLN3 (NCT03307304) and one for GM1 gangliosidosis (NCT00029965). Twenty-two CLN3 individuals underwent 28 anesthetic events (age median 11.0, IQR 8.4-15.3 years). Fifteen GM1 individuals had 19 anesthetic events (9.8, 7.1-14.7). All participants had the American Society of Anesthesiology classification of II (8/47) or III (39/47). Mean sedation durations were 186 (SD = 54; CLN3) and 291 (SD = 33; GM1) min. Individuals with GM1 (6/19, 31%) were more frequently prospectively intubated for sedation (CLN3 3/28, 11%). Minor adverse events associated with sedation occurred in 8/28 (28%, CLN3) and 6/19 (32%, GM1) individuals, frequencies within previously reported ranges. No major adverse clinical outcomes occurred in 47 anesthetic events in pediatric participants with either CLN3 or GM1 gangliosidosis undergoing research procedures. Sedation of pediatric individuals with rare neurometabolic diseases for research procedures is safe and allows for the collection of data integral to furthering their understanding and treatment.
    MeSH term(s) Adolescent ; Child ; Humans ; Anesthesia ; Anesthesiology ; beta-Galactosidase ; G(M1) Ganglioside ; Gangliosidosis, GM1/genetics ; Lysosomes ; Membrane Glycoproteins/genetics ; Molecular Chaperones/genetics ; Rare Diseases ; Retrospective Studies
    Chemical Substances beta-Galactosidase (EC 3.2.1.23) ; CLN3 protein, human ; G(M1) Ganglioside (37758-47-7) ; Membrane Glycoproteins ; Molecular Chaperones
    Language English
    Publishing date 2022-12-02
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Intramural
    ZDB-ID 2108614-X
    ISSN 1552-4833 ; 0148-7299 ; 1552-4825
    ISSN (online) 1552-4833
    ISSN 0148-7299 ; 1552-4825
    DOI 10.1002/ajmg.a.63064
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Characterization of seizures and EEG findings in creatine transporter deficiency due to SLC6A8 mutation.

    Abdennadher, Myriam / Inati, Sara K / Rahhal, Samar / Khan, Omar / Bartolini, Luca / Thurm, Audrey / Theodore, William / Miller, Judith S / Porter, Forbes D / Bianconi, Simona

    American journal of medical genetics. Part A

    2023  Volume 194, Issue 2, Page(s) 337–345

    Abstract: Seizures occur in up to 59% of boys with creatine transporter deficiency (CTD). While seizure phenotypes have been previously described, electroencephalogram (EEG) findings have only been reported in several case reports. In this prospective ... ...

    Abstract Seizures occur in up to 59% of boys with creatine transporter deficiency (CTD). While seizure phenotypes have been previously described, electroencephalogram (EEG) findings have only been reported in several case reports. In this prospective observational study, we report seizure characteristics and EEG findings in combination with neurobehavioral and SLC6A8 pathogenic variants in twenty males with CTD. Eighteen study participants (SP) underwent video-EEG, and seven had follow-up EEG recordings. Seizures typically occurred by age of 2 years. Thirteen (65%) had non-febrile seizures, requiring anti-seizure medications in nine. Four had febrile seizures. Seizures were bilateral tonic-clonic in 7 SP and focal impaired awareness in 5 SP; often responding to 1 to 2 antiseizure medications. EEG showed slowing in 5 SP, beta activity in 6 SP, and focal/multifocal, and/or generalized epileptiform activity in 9 SP. Follow-up EEGs in 7 SP showed emergence of epileptiform activity in 1 SP, and increased activity in 2 SP. In conclusion, seizures were frequent in our cohort but tended to respond to antiseizure medications. Longitudinal follow up provided further insight into emergence of seizures and EEG abnormalities soliciting future studies with long term follow up. Biomarkers of epileptogenicity in CTD are needed to predict seizures in this population.
    MeSH term(s) Male ; Humans ; Child, Preschool ; Electroencephalography ; Brain Diseases, Metabolic, Inborn ; Mutation ; Seizures/diagnosis ; Seizures/drug therapy ; Seizures/genetics ; Nerve Tissue Proteins ; Plasma Membrane Neurotransmitter Transport Proteins/genetics ; Mental Retardation, X-Linked ; Creatine/deficiency
    Chemical Substances SLC6A8 protein, human ; Nerve Tissue Proteins ; Plasma Membrane Neurotransmitter Transport Proteins ; Creatine (MU72812GK0)
    Language English
    Publishing date 2023-10-18
    Publishing country United States
    Document type Observational Study ; Journal Article
    ZDB-ID 2108614-X
    ISSN 1552-4833 ; 0148-7299 ; 1552-4825
    ISSN (online) 1552-4833
    ISSN 0148-7299 ; 1552-4825
    DOI 10.1002/ajmg.a.63418
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top